GlassScriptPhysician profile
David B Mcconda
NPI 1962713362
$4,653.15
in general payments reported to CMS, 2019-2025
13 companies · $349 in 2025
The $349 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $155 · 2021: $2,388 · 2022: $464 · 2023: $1,196 · 2024: $100 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $971 · Travel and Lodging: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $971.18 |
| Travel and Lodging | $674.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $2,111.60 | 2021-2023 | Other - Miscellaneous |
| Abbott Laboratories | $1,319.67 | 2020-2025 | Proclaim, Penta, Eterna |
| Si-Bone, INC. | $626.93 | 2021-2025 | |
| Globus Medical, INC. | $160.54 | 2025 | Senza |
| Stryker Corporation | $159.45 | 2020-2021 | |
| Alpha Orthopedic Systems | $109.89 | 2022 | |
| Smith+Nephew, INC. | $37.41 | 2021-2022 | |
| Medtronic, INC. | $31.11 | 2021-2024 | Synchromedii |
| Amgen INC. | $28.50 | 2021 | |
| Radius Health, INC. | $21.02 | 2021 | |
| Pacira Therapeutics, INC. | $20.26 | 2021 | |
| Providence Medical Technology, INC. | $15.13 | 2021 | |
| Baudax Bio INC. | $11.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mcconda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.